Stem cell therapy may involve the use of either a patient’s own stem cells or donor-derived stem cells. With autologous therapy, the cells are collected from the patient and prepared for subsequent use. One of the key advantages of using a patient’s own cells is their high biological compatibility with the body, which minimizes the risk of immune rejection.
Donor stem cells, used in allogeneic therapy, are obtained from another person, such as a compatible family member or an appropriate donor. Because these cells come from a different individual, compatibility is an important consideration, and the potential risks and benefits are carefully evaluated before treatment. At Mardaleishvili Medical Centre, both approaches are used, allowing the treatment strategy to be tailored to each patient’s individual condition and medical needs.
Which Type of Stem Cells Is Better?
The choice between own and donor stem cells is not simply a matter of choosing one type over the other. Each approach has its own potential advantages and considerations, and the most suitable option depends on the individual clinical situation. Factors such as the patient’s condition, treatment goals, the quality and availability of their own cells, and the potential suitability of donor cells may all play a role in the decision.
There is no single approach that is best for every patient. At Mardaleishvili Medical Centre, both autologous and donor stem cell therapies are available. Our specialists evaluate each patient individually and recommend the most appropriate cell source based on their medical needs and treatment plan.
